BioElectronics(BIEL)
$0.000.00 (0.00%)
BIEL
BioElectronics financials statements
$0.00
At close:0.00 (0.00%)
BioElectronics (BIEL) Ratios
89 Followers
BioElectronics Ratios
BIEL's free cash flow for Q1 2023 was $-64.03K. For the 2023 fiscal year, BIEL's free cash flow was increased by $0.00 and operating cash flow was $-64.03K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.04 | 0.01 | 0.04 | 0.07 | 0.01 |
| Quick Ratio | 0.03 | 0.00 | 0.03 | 0.03 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Solvency Ratio | -0.03 | -0.05 | -0.03 | -0.03 | -0.01 |
| Operating Cash Flow Ratio | -0.04 | -0.04 | -0.08 | -0.13 | -0.05 |
| Short-Term Operating Cash Flow Coverage | -0.08 | -0.08 | -0.15 | -0.25 | -0.08 |
| Net Current Asset Value | $ -17.94M | $ -17.41M | $ -16.48M | $ -15.76M | $ -15.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 114.42 | 358.50 | 102.72 | 56.32 | 159.06 |
| Debt-to-Equity Ratio | -0.91 | -0.89 | -0.90 | -0.89 | -0.88 |
| Debt-to-Capital Ratio | -9.86 | -8.28 | -9.00 | -8.46 | -7.52 |
| Long-Term Debt-to-Capital Ratio | -4.03 | -3.44 | -3.17 | -3.42 | -1.59 |
| Financial Leverage Ratio | -0.01 | -0.00 | -0.01 | -0.02 | -0.01 |
| Debt Service Coverage Ratio | 0.03 | -0.15 | -0.10 | -0.15 | 0.04 |
| Interest Coverage Ratio | 0.13 | -0.73 | -0.61 | -0.78 | -0.49 |
| Debt to Market Cap | 1.65 | 3.14 | 3.00 | 1.15 | 0.52 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 200.40 | -39.53 | -54.05 | -40.89 | 82.41 |
| Profitability Margins | |||||
| Gross Profit Margin | 84.87% | 73.32% | 65.26% | 68.77% | 49.43% |
| EBIT Margin | 15.91% | -79.17% | -38.38% | -48.55% | 1.54% |
| EBITDA Margin | 15.91% | -79.17% | -38.38% | -48.55% | 10.06% |
| Operating Profit Margin | 15.91% | -79.17% | -38.38% | -48.55% | -9.60% |
| Pretax Profit Margin | -104.28% | -187.62% | -101.13% | -110.96% | -18.01% |
| Net Profit Margin | -104.28% | -187.62% | -101.13% | -110.96% | -18.01% |
| Continuous Operations Profit Margin | -104.28% | -187.62% | -101.13% | -110.96% | -18.01% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | -655.25% | 236.99% | 263.52% | 228.54% | 187.65% |
| Return on Assets (ROA) | -374.04% | -2148.02% | -500.60% | -313.73% | -345.49% |
| Return on Equity (ROE) | 2.97% | 5.35% | 4.39% | 4.98% | 1.92% |
| Return on Capital Employed (ROCE) | -2.28% | 10.02% | 6.95% | 9.64% | 2.64% |
| Return on Invested Capital (ROIC) | -4.92% | 20.93% | 16.65% | 20.61% | 8.70% |
| Return on Tangible Assets | -374.04% | -2148.02% | -500.60% | -313.73% | -345.49% |
| Earnings Yield | -5.39% | -18.84% | -14.63% | -6.40% | -1.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.73 | 118.05 | 7.24 | 9.01 | 27.89 |
| Payables Turnover | 0.08 | 0.13 | 0.31 | 0.30 | 1.26 |
| Inventory Turnover | 2.51 | 4.23 | 6.05 | 1.74 | 32.22 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 3.59 | 11.45 | 4.95 | 2.83 | 19.19 |
| Working Capital Turnover Ratio | -0.14 | -0.13 | -0.19 | -0.15 | -0.23 |
| Cash Conversion Cycle | -4217.04 | -2742.34 | -1067.50 | -968.35 | -266.11 |
| Days of Sales Outstanding | 77.20 | 3.09 | 50.38 | 40.53 | 13.09 |
| Days of Inventory Outstanding | 145.71 | 86.20 | 60.34 | 209.20 | 11.33 |
| Days of Payables Outstanding | 4439.94 | 2831.62 | 1178.22 | 1218.08 | 290.52 |
| Operating Cycle | 222.91 | 89.29 | 110.72 | 249.72 | 24.41 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -54717.67 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -54717.67 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 |
| Operating Cash Flow to Sales Ratio | -0.30 | -0.33 | -0.47 | -0.68 | -0.20 |
| Free Cash Flow Yield | -1.53% | -3.32% | -6.80% | -3.90% | -1.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -18.56 | -5.31 | -6.84 | -15.63 | -87.88 |
| Price-to-Sales (P/S) Ratio | 19.35 | 9.96 | 6.91 | 17.35 | 15.82 |
| Price-to-Book (P/B) Ratio | -0.55 | -0.28 | -0.30 | -0.78 | -1.68 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -65.27 | -30.10 | -14.71 | -25.64 | -79.52 |
| Price-to-Operating Cash Flow Ratio | -65.27 | -30.10 | -14.71 | -25.64 | -79.52 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 322.01 | -52.12 | -72.07 | -76.62 | 239.73 |
| Enterprise Value | 26.17M | 20.47M | 19.77M | 26.32M | 38.81M |
| EV to EBITDA | 322.01 | -52.12 | -72.07 | -76.62 | 239.73 |
| EV to Sales | 51.25 | 41.26 | 27.66 | 37.20 | 24.11 |
| EV to Free Cash Flow | -172.83 | -124.68 | -58.83 | -54.98 | -121.17 |
| EV to Operating Cash Flow | -172.83 | -124.67 | -58.83 | -54.98 | -121.17 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | -6.55 | 2.37 | 2.64 | 2.29 | -11.71 |
| Research & Development to Revenue | 0.25 | 0.54 | 0.38 | 0.33 | 0.20 |
| SG&A to Revenue | 0.44 | 0.99 | 0.00 | 0.00 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.28 | 0.18 | 0.46 | 2.11 | 1.11 |
Currency in USD

